The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
William Blair International Ldrs R6 WILJX
- NAV / 1-Day Return 21.15 / +0.62 %
- Total Assets 1.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.850%
- Distribution Fee Level Above Average
- Share Class Type Retirement, Large
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield 0.46%
- Turnover 50%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis WILJX
Will WILJX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 3.90 | 46.2 Mil | Healthcare |
Taiwan Semiconductor Manufacturing Co Ltd | 2.77 | 32.9 Mil | Technology |
AstraZeneca PLC | 2.59 | 30.8 Mil | Healthcare |
Reliance Industries Ltd | 2.47 | 29.3 Mil | Energy |
Hoya Corp | 2.42 | 28.8 Mil | Healthcare |
ASML Holding NV | 2.33 | 27.7 Mil | Technology |
London Stock Exchange Group PLC | 2.31 | 27.5 Mil | Financial Services |
Compass Group PLC | 2.29 | 27.2 Mil | Consumer Cyclical |
Icon PLC | 2.24 | 26.6 Mil | Healthcare |
MercadoLibre Inc | 2.22 | 26.4 Mil | Consumer Cyclical |